Alvotech shares surge following second FDA approval
Full story
Alvotech shares increased by 7% during today's trading. This rise follows an announcement that the US Food and Drug Administration approved a new manufacturing process. The approval concerns the company's drug Simlandi.
Shares in Alvotech have risen by 7% in trading today, as the company announced that the US Food and Drug Administration (FDA) had approved a new manufacturing process for its drug Simlandi.